Pricing Log in Create free account

COSCIENS Biopharma Inc. (CSCIF) vs Jaguar Animal Health, Inc. (JAGX)

COSCIENS Biopharma Inc. and Jaguar Animal Health, Inc. are both Biotechnology companies. COSCIENS Biopharma Inc. and Jaguar Animal Health, Inc. are of similar size ($8.9M and $8.6M). Jaguar Animal Health, Inc. trades at the lower P/E: 0.0× against 1.0×. Jaguar Animal Health, Inc. grew revenue faster over the last twelve months: 135.5% against −3.02%. COSCIENS Biopharma Inc. has the higher net margin (75.1% vs −188.5%) and the higher return on invested capital (−40.6% vs −28,393.6%). Across the 19 metrics below, Jaguar Animal Health, Inc. leads on 10 and COSCIENS Biopharma Inc. on 9.

Valuation

Metric CSCIF JAGX Biotechnology median
P/E 1.03 0.00 8.50
P/S 0.78 0.01 9.71
P/B 0.46 0.04 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.13 0.64
EV/Sales 0.17 (0.11) 9.21
Earnings yield 96.93% 51,230.90% (33.15%)
Free cash flow yield (45.48%) (3,867.38%) (25.50%)

Profitability

Metric CSCIF JAGX Biotechnology median
Gross margin 46.48% 82.31% 65.16%
Operating margin (71.13%) (93.10%) 0.00%
Net margin 75.11% (188.46%) 0.00%
Free cash flow margin (40.36%) (24.03%) 0.00%
Return on equity 59.74% (1,125.38%) (56.36%)
Return on assets 28.24% (127.14%) (48.04%)
Return on invested capital (40.56%) (28,393.64%) 0.00%

Growth

Metric CSCIF JAGX Biotechnology median
Revenue growth (TTM) (3.02%) 135.52% 6.02%
EPS growth (last fiscal year) 44.86% 82.42% 30.26%
Revenue growth, 5-year CAGR 15.47% 4.17% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CSCIF JAGX Biotechnology median
Debt to equity 0.00 0.35 0.00
Current ratio 4.33 0.69 4.72
Net debt to EBITDA 0.78 (0.17) 0.96

Dividend

Metric CSCIF JAGX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CSCIF JAGX Biotechnology median
Market cap 8.57m 8.93m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack